Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN study.

Saved in:
Bibliographic Details
Title: Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN study.
Authors: Phan LT; Cureos Research, Sydney, NSW, Australia., Chin J; Cureos Research, Sydney, NSW, Australia., Broadhead GK; Cureos Research, Sydney, NSW, Australia., Hong TH; Cureos Research, Sydney, NSW, Australia., Mehta H; Sydney Retina Clinic, Sydney, NSW, Australia; Strathfield Retina Clinic, Strathfield, NSW, Australia., Chang JH; Eastwood Eye Specialists, Eastwood, NSW, Australia., Fraser-Bell S; Sydney Retina Clinic, Sydney, NSW, Australia; Save Sight Institute, The University of Sydney, Sydney, NSW, Australia; Lane Cove Eye Surgery, Lane Cove, NSW, Australia; Department of Ophthalmology, Sydney Eye Hospital, Sydney, NSW, Australia., Cheung CMG; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Sun CZ; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Luckie AP; EyeClinic Albury Wodonga, Albury, NSW, Australia., Wickremasinghe SS; Retina Specialists Victoria, Rowville, VIC, Australia., Liew G; South West Retina, Liverpool, NSW, Australia., Gilhotra JS; Adelaide Eye and Retina Centre, Adelaide, SA, Australia., Simunovic MP; Eastern Suburbs Eye Specialists, Bondi Junction, NSW, Australia., Verma N; Hobart Eye Surgeons, Hobart, TAS, Australia., Chang AA; Cureos Research, Sydney, NSW, Australia; Sydney Retina Clinic, Sydney, NSW, Australia; Strathfield Retina Clinic, Strathfield, NSW, Australia. Electronic address: achang@sydneyretina.com.au.
Source: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) [Asia Pac J Ophthalmol (Phila)] 2026 Mar-Apr; Vol. 15 (2), pp. 100299. Date of Electronic Publication: 2026 Mar 03.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase IV
Journal Info: Publisher: Elsevier Inc. on behalf of Asia-Pacific Academy of Ophthalmology and Academy of Asia-Pacific Professors of Ophthalmology Country of Publication: United States NLM ID: 101583622 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-0989 (Electronic) Linking ISSN: 21620989 NLM ISO Abbreviation: Asia Pac J Ophthalmol (Phila) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-0989
DOI:10.1016/j.apjo.2026.100299